Literature DB >> 11571751

Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas.

S R Patel1, J Jenkins, N Papadopolous, M A Burgess, C Plager, J Gutterman, R S Benjamin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11571751     DOI： 10.1002/1097-0142(20010901)92:5<1347::aid-cncr1456>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  21 in total

Review 1.  Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis?

Authors:  Roland Haubner
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

2.  Effects of a monoclonal anti-alphavbeta3 integrin antibody on blood vessels - a pharmacodynamic study.

Authors:  Dahua Zhang; Thomas Pier; Douglas G McNeel; George Wilding; Andreas Friedl
Journal:  Invest New Drugs       Date:  2006-09-26       Impact factor: 3.850

Review 3.  Liver regeneration and tumor stimulation--a review of cytokine and angiogenic factors.

Authors:  Christopher Christophi; Nadia Harun; Theodora Fifis
Journal:  J Gastrointest Surg       Date:  2008-01-08       Impact factor: 3.452

4.  Small molecular peptide-ScFv αvβ3 conjugates specifically inhibit lung cancer cell growth in vitro and in vivo.

Authors:  Qianqian Qiu; Qiongyao Wang; Changxu Deng; Yanqin Sun; Taoliang Chen; Linlang Guo; Fan Zhang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

5.  Integrin targeted therapeutics.

Authors:  Melissa Millard; Srinivas Odde; Nouri Neamati
Journal:  Theranostics       Date:  2011-02-17       Impact factor: 11.556

6.  Integrin alpha(v)beta(3)-Targeted Cancer Therapy.

Authors:  Zhaofei Liu; Fan Wang; Xiaoyuan Chen
Journal:  Drug Dev Res       Date:  2008       Impact factor: 4.360

7.  Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors.

Authors:  Catherine Delbaldo; Eric Raymond; Karina Vera; Luz Hammershaimb; Karen Kaucic; Stéphanie Lozahic; Michel Marty; Sandrine Faivre
Journal:  Invest New Drugs       Date:  2007-09-18       Impact factor: 3.850

Review 8.  Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner.

Authors:  Thomas Dittmar; Christoph Heyder; Eva Gloria-Maercker; Wolfgang Hatzmann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2007-09-08       Impact factor: 5.150

Review 9.  Miniaturized pre-clinical cancer models as research and diagnostic tools.

Authors:  Maria Håkanson; Edna Cukierman; Mirren Charnley
Journal:  Adv Drug Deliv Rev       Date:  2013-12-01       Impact factor: 15.470

10.  Interleukin-12 inhibits tumor growth in a novel angiogenesis canine hemangiosarcoma xenograft model.

Authors:  Nasim Akhtar; Marcia L Padilla; Erin B Dickerson; Howard Steinberg; Matthew Breen; Robert Auerbach; Stuart C Helfand
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.